FIGURE 1.
Effect of empagliflozin (10 and 25 mg doses pooled) versus placebo on uric acid (UA) levels (mg/dL) over time (on‐treatment). Mixed‐effect model repeated measures analyses included the continuous fixed effects of baseline UA and baseline glycated haemoglobin at each visit and discrete fixed effects for treatment at each visit, sex, region, baseline estimated glomerular filtration rate, baseline body mass index and last projected visit